All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
| Fri 2016-12-30 to Thu 2025-05-01 |
YTD
Return |
TRR
Price |
||||
|---|---|---|---|---|---|---|
| GSK × |
+14.07%
2025-05-01 |
17.61 TRR
2025-05-01 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Fri 2016-12-30 to Thu 2025-05-01 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| GSK × |
+9.96%
+1.15%/yr |
−0.32%/yr
(R2=0.007) |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Fri 2016-12-30 to Thu 2025-05-01 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| GSK × |
$10,000.00
2016-12-30 |
$10,996.03
2025-05-01 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Year | GSK |
|---|---|
| 2025 (YTD) | +14.07% |
| 2024 | −7.79% |
| 2023 | +6.17% |
| 2022 | −23.23% |
| 2021 | +18.29% |
| 2020 | −18.87% |
| 2019 | +26.24% |
| 2018 | +11.54% |
| 2017 | −5.08% |
| 2016 | −0.09% |
| 2015 | −1.09% |
| 2014 | −16.39% |
| 2013 | +26.90% |
| 2012 | −1.15% |
| 2011 | +18.96% |
| 2010 | −3.67% |
| 2009 | +16.08% |
| 2008 | −22.40% |
| 2007 | −4.74% |
| 2006 | +5.23% |
| 2005 | +6.17% |
| 2004 | +2.21% |
| 2003 | +26.27% |
| 2002 | −23.46% |
| 2001 | −11.04% |
| 2000 | +0.69% |
| 1999 | −20.10% |
| 1998 | +45.79% |
| 1997 | +53.14% |
| 1996 | +14.08% |
| 1995 | +41.48% |
| 1994 | +0.33% |
| 1993 | −12.88% |
| 1992 | −25.11% |
| 1991 | +92.93% |
| 1990 | +22.86% |
| 1989 | +32.49% |
| 1988 | +2.44% |
| 1987 | +15.33% |
| 1986 | +37.64% |
| 1985 | +68.47% |
| 1984 | −1.95% |
| Fri 2016-12-30 to Thu 2025-05-01 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| GSK × | −19.10% |
−41.46%
2022-09-27 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||